Lin Xianghang, Yang Yang, Zhu Wenzhang, He Xiaorong, Liu Yunliang
Department of Otolaryngology, Fujian Children's Hospital (Fujian Branch of Shanghai Children's Medical Center), College of Clinical Medicine for Obstetrics & Gynecology and Pediatrics, Fujian Medical University Fuzhou 350014 China
Department of Otolaryngology, Fujian Maternity and Child Health Hospital, College of Clinical Medicine for Obstetrics & Gynecology and Pediatrics, Fujian Medical University Fuzhou 350001 China.
Nanoscale Adv. 2024 Nov 26;7(2):549-559. doi: 10.1039/d4na00712c. eCollection 2025 Jan 14.
MicroRNAs (miRNAs) play crucial roles in the regulation of immune cell differentiation and the immune response during allergic rhinitis (AR). Studies have shown that miRNA-155 is significantly upregulated in AR pathogenesis. Therefore, miRNA-155 can be used as a biomarker for AR diagnosis. Although fluorescent biosensors based on upconversion nanoparticles (UCNPs) have made significant advances in the detection of miRNAs, developing UCNPs with polymer coatings, efficient surface passivation, and DNA functionalization for hybrid sensing in biological media remains challenging. Herein, hairpin DNA1 (H1) is modified into a thin polysulfonic acid layer on UCNPs by sulfonamide bonds, and the fluorescence of the UCNPs is quenched by the fluorescence resonance energy transfer (FRET) process of BHQ3 carried by H1. When the target miRNA-155 is present, the hairpin structure of H1 is opened, allowing BHQ3 to move away from the UCNP surface, and the fluorescence of UCNP is restored. At the same time, hairpin DNA1 (H2) can combine with H1 to replace the miRNA-155 that is bound to H1 with the help of the opening stem ring structure of H1, and the replaced miRNA-155 can continue to react with H1 to amplify the fluorescence signal. Under the optimal experimental conditions, the linear range of miRNA-155 is 0.01-3 nM, with a detection limit of 1.14 pM. Furthermore, the constructed biosensor has been applied to determine miRNA-155 in serum samples, and the spiked recoveries range from 99.8% to 104.8%, which indicates that the developed assay has potential applications in monitoring allergic rhinitis or other miRNA related diseases.
微小RNA(miRNA)在变应性鼻炎(AR)期间的免疫细胞分化调节和免疫反应中起关键作用。研究表明,miRNA-155在AR发病机制中显著上调。因此,miRNA-155可用作AR诊断的生物标志物。尽管基于上转换纳米颗粒(UCNP)的荧光生物传感器在miRNA检测方面取得了显著进展,但开发具有聚合物涂层、高效表面钝化和用于生物介质中混合传感的DNA功能化的UCNP仍然具有挑战性。在此,发夹DNA1(H1)通过磺酰胺键修饰在UCNP上形成一层薄的聚磺酸层,并且UCNP的荧光通过H1携带的BHQ3的荧光共振能量转移(FRET)过程被淬灭。当目标miRNA-155存在时,H1的发夹结构打开,使BHQ3从UCNP表面移开,UCNP的荧光恢复。同时,发夹DNA1(H2)可以与H1结合,借助H1的开放茎环结构取代与H1结合的miRNA-155,被取代的miRNA-155可以继续与H1反应以放大荧光信号。在最佳实验条件下,miRNA-155的线性范围为0.01 - 3 nM,检测限为1.14 pM。此外,构建的生物传感器已应用于测定血清样本中的miRNA-155,加标回收率范围为99.8%至104.8%,这表明所开发的检测方法在监测变应性鼻炎或其他与miRNA相关的疾病方面具有潜在应用。